Agreement among three quality of life measures in patients with ALS

Citation
Ps. Smith et al., Agreement among three quality of life measures in patients with ALS, AMYOTROPH L, 1(4), 2000, pp. 269-275
Citations number
19
Categorie Soggetti
Neurology
Journal title
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
ISSN journal
14660822 → ACNP
Volume
1
Issue
4
Year of publication
2000
Pages
269 - 275
Database
ISI
SICI code
1466-0822(200009)1:4<269:AATQOL>2.0.ZU;2-H
Abstract
AIM: To determine the concurrent validity of three self-administered health -related quality of life (HRQOL) questionnaires when administered to patien ts with amyotrophic lateral sclerosis (ALS). BACKGROUND: ALS is the most common motor neuron disease among adults. As a rapidly progressive and fatal disease, ALS has devastating effects on the p atient's relationships, functional capacity and mental health. HRQOL measur es include information about patients' physical impairments, functional lev el, and psychosocial status, This study compares a tool designed for the AL S population, the Sickness Impact Profile ALS-19 (SIP/ALS-19), and two tool s designed to be used in any population, the Quality of Wellbeing Scale SA (QWB SA), and the SF-36 Health Survey (SF-36). Correlation of the scores wo uld suggest that each tool is valid as a stand-alone measurement of quality of life for this patient population. METHODS: The SIP/ALS-19, the SF-36, and the QWB SA were self-administered t o 19 subjects diagnosed with ALS. The scores for each test were ranked and analyzed for agreement using the Spearman rank correlation coefficient. Res ults: The SIP/ALS-19 demonstrated moderate to good correlation with the QWB SA and fair correlation with the SF-36. The SF-36 had little to no correla tion with the QWB SA. CONCLUSIONS: The study did not demonstrate significant correlation among th e three quality of life measures. The SIP/ALS-19, SF-36, and QWB SA each ha ve a different focus in measuring HRQOL. The healthcare practitioner should consider the patient's stage of disease, treatment goals, and type of inte rventions planned when selecting a HRQOL tool for the ALS patient.